CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors.
Abstract
Background
Growing evidence supports choroid plexus (CP) involvement in MS pathophysiology, but phase-specific associations according to recent inflammatory activity and longitudinal dynamics remain unclear.
Objective
To characterize CP alterations in MS using volumetric and quantitative magnetic resonance imaging (MRI) and explore associations with neuroinflammation and neurodegeneration.
Methods
We analyzed cross-sectional and 2-year longitudinal data from 101 patients with active relapsing MS (RMS), 83 with inactive progressive MS (PMS), and 100 controls, with MS groups stratified by inflammatory activity within the prior year. CP volume, quantitative T1, and magnetization transfer saturation (MTsat) were assessed alongside imaging, serum, and clinical measures, with validation in a second cohort (62 active/357 inactive MS).
Results
CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes. Associations with brain microstructural damage were more pronounced in periventricular regions, compatible with a surface-in pattern. Similar associations were observed in controls, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors. Longitudinally, CP volume increased exclusively in active RMS, with faster expansion associated with thalamic atrophy. CP MTsat was associated with cortical and paramagnetic rim lesions in inactive PMS.
Conclusion
CP enlargement is consistent across MS phases. Longitudinal expansion occurs in active inflammatory disease and is associated with neurodegenerative changes.
Standardized acquisition and segmentation, harmonized cognitive assessment, and adequately powered longitudinal studies are needed to establish their independent and predictive value for choroid plexus volume, as the evidence remains limited and methodologically heterogeneous.
Weronika Galus, Patrycja Romaniszyn-Kania, Aleksandra Urantówka et al.· Brain Science· 0 citations
Findings suggest relative preservation of CPV in MOGAD and support a closer association of CPV enlargement with disease‐related structural changes in MS than in MOGAD.
Jae-Won Hyun, Shaun G. Hong, N. Park et al.· Annals of Clinical and Trans...· 0 citations
These findings link CP enlargement to neuropathologically confirmed AD burden and CI, supporting further investigation of CP structure and function in AD.
Francis A Fernandes, Avyarthana Dey, Andy Ma et al.· The journal of prevention of...· 0 citations
Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity, and shows promise as a rapid biomarker for MS diagnosis.
Blake Benyard, Dushyant Kumar, Neil E. Wilson et al.· Research Square· 0 citations
CP enlargement is associated with glymphatic diffusion, and its relationship with cognitive performance varies across DTI-ALPS index values, suggesting that interactions between CSF regulatory systems may correlate with cognitive performance in a state-dependent manner.
N. Tan, T. Welton, Yi Jayne Tan et al.· Frontiers in Aging Neuroscie...· 0 citations
Preserved PCA neurovascular function is associated with lower WM lesion burden, measured using conventional MRI, in MS patients with lower disability and better cognition, a finding that may inform risk stratification and guide future therapeutic targets.
C. Duque, J. Sargento-Freitas, Roumen Balabanov et al.· Therapeutic Advances in Neur...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.